EUVIMEDEUVIMED entdecken
Multizentrische StudieLeitlinie

Trends in antithrombotic therapy and clinical outcomes for percutaneous coronary intervention in Japan following the 2020 JCS guideline focused update: findings from the SAKURA PCI2 Antithrombotic Registry

Riku Arai, Nobuhiro Murata, Keisuke Kojima, Michiaki Matsumoto, Naoya Matsumoto, Tomoyuki Morikawa, Wataru Atsumi, Eizo Tachibana, Hironori Haruta, Takaaki Kogo, Yasunari Ebuchi, Kazumiki Nomoto und 7 weitere

Heart and Vessels · 2025

DOI: 10.1007/s00380-024-02493-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Heart and Vessels, 2025. Verfasst von Riku Arai und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Nihon University School of Medicine Itabashi Hospital, 30-1 Ohyaguchi-Kamicho, Itabashi-ku, …. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Registries, Platelet Aggregation Inhibitors, Fibrinolytic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionRegistriesPlatelet Aggregation InhibitorsFibrinolytic AgentsPractice Guidelines as TopicCoronary Artery DiseaseHumansJapanMaleFemaleAgedProspective StudiesMiddle AgedTreatment OutcomeHemorrhageRisk FactorsTime FactorsIncidenceDual Anti-Platelet TherapyRisk AssessmentAged, 80 and over

Stichwörter der Autor:innen

BARC 3 or 5 bleedingJ-HBRMACCEPlanned short DAPT

Substanzen

Platelet Aggregation InhibitorsFibrinolytic Agents

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Nihon University School of Medicine Itabashi Hospital, 30-1 Ohyaguchi-Kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
  • Division of Cardiology, Department of Internal Medicine, Nihon University School of Medicine Itabashi Hospital, 30-1 Ohyaguchi-Kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. nov_murata@yahoo.co.jp.
  • Division of Cardiology, Nihon University Hospital, Tokyo, Japan.
  • Division of Cardiology, Kawaguchi Municipal Medical Center, Saitama, Japan.
  • Division of Cardiology, TMG Asaka Medical Center, Saitama, Japan.
  • Division of Cardiology, Tokyo Rinkai Hospital, Tokyo, Japan.

Zitieren

APA

Arai, R., Murata, N., Kojima, K., Matsumoto, M., Matsumoto, N., Morikawa, T., Atsumi, W., Tachibana, E., Haruta, H., Kogo, T., Ebuchi, Y., Nomoto, K., Arai, M., Arima, K., Mineki, T., Koyama, Y., Oiwa, K., Okumura, Y., & SAKURA PCI2 Antithrombotic Registry Investigators (2025). Trends in antithrombotic therapy and clinical outcomes for percutaneous coronary intervention in Japan following the 2020 JCS guideline focused update: findings from the SAKURA PCI2 Antithrombotic Registry. Heart and Vessels. https://doi.org/10.1007/s00380-024-02493-4

Vancouver

Arai R, Murata N, Kojima K, Matsumoto M, Matsumoto N, Morikawa T, et al. Trends in antithrombotic therapy and clinical outcomes for percutaneous coronary intervention in Japan following the 2020 JCS guideline focused update: findings from the SAKURA PCI2 Antithrombotic Registry. Heart and Vessels. 2025. doi:10.1007/s00380-024-02493-4

BibTeX
@article{Arai2025,
  author = {Arai, Riku and Murata, Nobuhiro and Kojima, Keisuke and Matsumoto, Michiaki and Matsumoto, Naoya and Morikawa, Tomoyuki and Atsumi, Wataru and Tachibana, Eizo and Haruta, Hironori and Kogo, Takaaki and Ebuchi, Yasunari and Nomoto, Kazumiki and Arai, Masaru and Arima, Ken and Mineki, Takashi and Koyama, Yutaka and Oiwa, Koji and Okumura, Yasuo and SAKURA PCI2 Antithrombotic Registry Investigators, SAKURA PCI2 Antithrombotic Registry Investigators},
  title = {Trends in antithrombotic therapy and clinical outcomes for percutaneous coronary intervention in Japan following the 2020 JCS guideline focused update: findings from the SAKURA PCI2 Antithrombotic Registry},
  journal = {Heart and Vessels},
  year = {2025},
  doi = {10.1007/s00380-024-02493-4}
}
Kostenlos starten →